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Architecture of the yeast Elongator complex
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Abstract
The highly conserved eukaryotic Elongator complex performs
specific chemical modifications on wobble base uridines of tRNAs,
which are essential for proteome stability and homeostasis. The
complex is formed by six individual subunits (Elp1-6) that are all
equally important for its tRNA modification activity. However, its
overall architecture and the detailed reaction mechanism remain
elusive. Here, we report the structures of the fully assembled yeast
Elongator and the Elp123 sub-complex solved by an integrative
structure determination approach showing that two copies of the
Elp1, Elp2, and Elp3 subunits form a two-lobed scaffold, which
binds Elp456 asymmetrically. Our topological models are consis-
tent with previous studies on individual subunits and further vali-
dated by complementary biochemical analyses. Our study provides
a structural framework on how the tRNA modification activity is
carried out by Elongator.
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Introduction
During the elongation phase of the ribosome-mediated translation
process, transient pausing events support proper domain folding
of the nascent polypeptide chains, which gain their three-
dimensional conformations immediately after they have left the
exit tunnel of the ribosomes, a process sometimes facilitated by
chaperones [1–3]. Previous studies indicated that specific base
modifications in the wobble base position of tRNAs are crucial to
maintain these highly dynamic and complex mechanisms. Mainly
because they influence the recognition rate and affinity between
incoming tRNAs and codons in the A site of the translating ribo-
some [4–6]. Interestingly, expansion of tRNA gene copy numbers
and isoacceptors correlate well with an increase in different tRNA
modification enzymes, suggesting an evolutionary selection for
optimizing translational efficiency and accuracy via different modi-
fication mechanisms [7].
The eukaryotic Elongator complex has been associated with a
plethora of cellular activities [8–10], but nowadays, it is widely
accepted that the main cellular function of the Elongator complex is
the formation of 5-methoxycarbonylmethyl-uridine (mcm5U), 5-
methoxycarbonylmethyl-2-thio-uridine (mcm5s2U), and 5-carba-
moylmethyl-uridine (ncm5U) in the wobble base position of 11
eukaryotic tRNAs [10]. Nevertheless, the detailed chemistry of the
Elongator modification reaction is insufficiently described, and the
role of the resulting modifications is not fully understood [11–13].
In particular, it is currently unclear how tRNA is delivered to the
active center and how the high modification turnover can be
achieved in the context of the full complex. The cellular role of Elon-
gator is of fundamental clinical relevance, as mutations affecting the
integrity and activity of this macromolecular complex are related to
the onset of neurodegenerative diseases [14–16], cancer [17,18],
and intellectual disabilities [19].
The fully assembled Elongator complex contains two copies of
each of its six subunits in vivo [20] and has an estimated molecular
weight of ~850 kDa. All subunits are highly conserved among
eukaryotes [21], which has also been experimentally proven by
cross species complementation analyses of genes encoding individ-
ual subunits and subdomains for yeast, insects, worms, plants, and
humans [15,22–26]. Shortly after the initial description of the three-
component Elongator sub-complex (Elp123) [27], an additionally
associated sub-complex containing subunits Elp4, Elp5, and Elp6
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[28] was identified under milder purification conditions. Crystal
structures are currently available for the homo-dimer of the Elp1 C-
terminus [29], Elp2 [30], and the RecA-like Elp456 hetero-hexamer
[20,31]. We recently determined the crystal structure of full-length
Elp3 from a bacterial homolog (DmcElp3), which shows high
sequence similarity to Elp3s from different organisms, including
yeast and humans [32]. The structure shows that the lysine acetyl
transferase (KAT) domain and the S-adenosylmethionine binding
domain (SAM) share a large and highly conserved interface that
creates a specific tRNA binding pocket and forms a composite active
site. However, no structural information is yet available for the
Elp123 sub-complex or the holoElongator (Elp1-6), precluding the
localization of the active center in relation to the other complex
components.
We set out to obtain structural information on the fully assem-
bled Elongator complex to better understand how the different sub-
units interact and together deliver modifiable tRNAs to the
enzymatically active Elp3 subunit. Here, we report the structures of
holoElongator and the Elp123 sub-complex at 31 A˚ and 27 A˚ resolu-
tion, respectively, by negative-stain electron microscopy (EM). In
addition, we describe the global interaction network between all six
individual subunits using crosslinking mass spectrometry (XL-MS)
and combine these results by an integrative modeling approach,
which allows us to localize all subunits and provide a topological
model of the full complex. The model enables us to anticipate how
the tRNA modification activity is carried out by this large molecular
machine and how the individual subunits contribute to its assembly
and activity.
Results
Endogenous Elongator and Elp123 sub-complex coexist as
stable complexes
In an initial attempt of assembling the Elongator complex from
individually purified proteins, expressed heterologously in Escheri-
chia coli, we were able to observe a direct interaction between
Elp1 and Elp3, and Elp1 and Elp456. Furthermore, these five sub-
units can also simultaneously interact with each other to form a
complex that comprises Elp1, Elp3, and the Elp456 sub-complex.
In contrast, we could not detect interactions between Elp2 and any
of the other subunits (Fig EV1A and B), supporting the idea that
further posttranslational modifications or chaperones are required
for the assembly of the complete Elongator complex [33,34].
Therefore, we focused on the characterization of endogenous
tandem-affinity purification (TAP)-tagged [35] Elongator, which
permits the purification of all six subunits directly from yeast. We
constructed yeast strains carrying endogenously TAP-tagged
versions of Elp1 and Elp6 and purified Elongator using previously
established purification protocols [20]. Consistent with sub-
stoichiometric cellular amounts of Elp456 in vivo [28,36,37], purifi-
cations of Elp1-TAP resulted in an excess of Elp123 sub-complex
[20], whereas Elp6-TAP purifications resulted in reduced quantities
but yielded highly pure, complete, and stoichiometric Elongator
complex. Large-scale preparations yielded sufficient amounts of
pure Elongator complex and Elp123 sub-complex to analyze their
overall architecture and shape by EM.
The Elp456 ring is asymmetrically positioned in the
holoElongator complex
In order to obtain the structure of Elongator, we used negative-stain
EM of the purified Elp6-TAP holoElongator complex. Highly pure
and stoichiometric holoElongator complex (Fig 1A) was stabilized
using low amounts of glutaraldehyde and reapplied to gel filtration.
A homogeneous population of two-lobed particles was observed
(Fig 1B) and 22,876 particles were selected and subjected to refer-
ence-free two-dimensional (2D) classification. The class averages
show a complex of around 260 × 170 A˚ formed by two lobes with a
cleft in between (Fig 1C). Interestingly, a hexameric ring-shaped
density protruding from one of the lobes is clearly visible (Fig 1C).
In addition, some of the side view 2D averages are asymmetric,
while some top views do not show a ring. Together, these observa-
tions suggest that only one copy of the hetero-hexameric Elp456 ring
asymmetrically interacts with the Elp123 sub-complex, as previ-
ously described [20].
The structure of holoElongator (Fig 1D) is ~270 A˚ in height,
~180 A˚ length, and ~160 A˚ width, and there is a clear correlation
between the class averages and the model back-projections (Fig 1C).
The Elongator model shows an estimated resolution of 31 A˚ based
on the Fourier Shell Correlation (FSC; Fig EV2A), and although the
angular assignment of particle orientations is well distributed, we
observed a preferential orientation, a commonly observed phenom-
enon in negative-stain EM (Fig EV2B). The structure consists of two
lobes linked in the upper part by the “arch” and divided by a “cleft”,
with two lateral bean-shaped densities, herein after referred as the
“wings”. A hexameric ring density stands out from one of the lobes
and the Elp456 crystal structure seamlessly fits into this density
(Fig 1E). Thus, although most of the Elongator density has the
shape of a nearly symmetrical two-lobed structure, the Elp456 ring
binds to the complex asymmetrically. The C-terminal domain (CTD)
of Elp1 observed in the crystal structure [29] can be also unambigu-
ously fitted to the holoElongator model (Fig 1F). The Elp1-CTD fits
to the arch of the Elongator complex with higher scores than in
other locations. Importantly, the fit of Elp1-CTD indicated the
correct handedness of the 3D reconstruction as the Elp1-CTD fits
significantly better in one of the mirrored holoElongator maps
(Fig EV2C and D). In addition, we used an experimental tilt-pair
validation approach to confirm the handedness and correctness of
our 3D reconstruction (Fig EV2E). However, we could not unam-
biguously place either the WD40 domains of Elp1 or the Elp2 and
Elp3 subunits, which fitted to various locations in the map with
similar cross-correlation scores, likely due to the limited resolution
of our reconstruction.
Two copies of the Elp1, Elp2, and Elp3 subunits form a symmetric
Elp123 sub-complex
To identify and localize the Elp1, Elp2, and Elp3 subunits, we
analyzed purified Elp123 sub-complex by negative-stain EM. As
previously described [20,28], Elp1-TAP purifications contain a
heterogeneous mixture of Elp123 and holoElongator, which makes
the structural analyses of these samples more complicated. Never-
theless, after slight modification of the purification protocol, we
managed to separate the two species and obtain sufficient amounts
of pure and stoichiometric Elp123 sub-complex. The purified Elp123
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sample (Fig 2A) was stabilized with low amounts of glutaraldehyde
and eluted from a gel filtration column at a volume expected for a
~610 kDa complex. This suggested that the Elp123 sub-complex in
isolation also harbors two copies of each of the three subunits, as
previously described for the full complex [20,28].
A major population of two-lobed particles was observed (Fig 2B)
and 50,034 particles were selected for reference-free 2D classifi-
cation. The class averages show different side views of a structure
that clearly resembles holoElongator but misses the ring-shaped
density (Fig 2C). 3D classification of the Elp123 sub-complex
showed the presence of a twofold symmetry axis, which was previ-
ously observed in some of the class averages (Fig EV3A). Thus, the
final C2-symmetrized model shows an estimated resolution of 27 A˚
according to the FSC (Fig EV3B and C). The back-projections of the
3D model correlate well with the class averages (Fig 2C), and the
overall angular assignment of particle orientations is well distrib-
uted (Fig EV3D).
The 3D reconstruction of the Elp123 complex closely resembles
the holocomplex. In detail, the two lobes are linked in the upper
part by the arch and are separated in the lower part by the cleft,
while they extend laterally into the wings (Fig 2D). The dimensions
of the Elp123 sub-complex are also similar in height (~170 A˚) and
length (~260 A˚) to the holocomplex, though it is more flattened in
the third dimension (~100 A˚) due to the absence of Elp456. Simi-
larly to the holoElongator, the dimer of the C-terminal domain
(CTD) of Elp1 could be fitted significantly better in one of the
mirrored Elp123 maps confirming the correct handedness of the
Elp123 reconstruction (Figs 2E and EV4A). The Elp1-CTD fits to the
arch in the equivalent position and the twofold symmetry axis of
the Elp1-CTD structure aligns with the symmetry axis of the map.
Interestingly, some of the class averages in top view seemed to
represent only partial Elp123 sub-complexes without one of the
wings (Fig EV4B). Indeed, 3D classification showed one class that
clearly resembled the intact Elp123 model missing one of the wings
(Fig EV4C). The refinement of this class yielded an asymmetric
model at 31 A˚ resolution based on the FSC (Fig EV4D). Back-projec-
tions of the 3D model correspond well with the class averages
(Fig EV4B). A difference map between the full Elp123 model and
the asymmetric model rendered, apart from a minor difference in
the bottom part, a bean-shaped density (Fig EV4E). Our group also
independently solved the yeast Elp2 structure at 2.8 A˚ resolution
(Appendix Table S1 and Fig EV4F), which is highly similar
A
C E F
B D
Figure 1. EM reconstruction of endogenous holoElongator.
A SDS–PAGE gel showing the purified holoElongator complex used as input for gel filtration. Protein bands marked with asterisks presumably correspond to different
phosphorylation states of Elp1 that have been previously described [34].
B Representative negative-stain EM field of the holoElongator complex. Particles in side and tilted views are highlighted. Scale bar, 50 nm.
C Reference-free class averages and back-projections of the holoElongator model. Hexameric ring-shaped densities and the asymmetric side view are indicated
(arrowheads). Scale bar, 20 nm.
D EM reconstruction of the holoElongator complex at 31 Å resolution.
E Fitting of the Elp456 crystal structure into the ring density of the holoElongator reconstruction.
F Fitting of the Elp1 CTD into the holoElongator reconstruction.
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(r.m.s.d. = 1.19 A˚686Ca) to the previously published Elp2 structure
[30]. Both Elp2 structures can be seamlessly fitted in the wings of
the Elongator complex (Fig 2F), but due to the pseudo symmetric
shape of its two WD40 domains it is not possible to know the exact
orientation of the Elp2 at the attained resolution.
In summary, the presented 3D models allow us to position the
CTD of Elp1 within the arch and the Elp2 within the wings, though
the precise orientation of Elp2 is still unclear. Moreover, the Elp456
binds asymmetrically to one of the lobes formed by single copies of
Elp1, Elp2, and Elp3. In contrast, the two N-terminal WD40
domains of Elp1 and the Elp3 subunit fit in different locations with
similar scores, precluding their placement solely based on the EM
maps and requiring additional restraints for their unambiguous
localization.
A tight network of interactions connects the Elp123 and the
Elp456 sub-complexes
In order to identify contacts between all the individual subunits and
obtain additional spatial restraints, we performed XL-MS analyses
(Fig 3 and Appendix Fig S1A). In summary, we detected 41 unique
inter-subunits and 75 intra-subunit highly confident crosslinks. The
crosslinks were deemed highly confident if their ld (linear discrimi-
nant) confidence score, as calculated by xProphet [38], was ≥ 30
(Appendix Table S2). Although many crosslinks appear in flexible
regions, we were able to validate our approach by observing the
expected distance (< 30 A˚) between several lysine residue pairs
present in the structured parts of the previously published crystal
structures of Elp2, Elp3, and Elp456 and that had been identified as
high confidence crosslinks (Appendix Fig S1B and C). Although the
used Elp1-TAP sample contained an excess of Elp123, we were able
to detect a tight network of interactions between the Elp123 and
Elp456 sub-complexes. Importantly, Elp3 and Elp4 extensively
crosslink to both the N- and C-terminal regions of Elp1 (Fig 3).
Moreover, the exclusive presence of inter-subunit crosslinks on one
of the sides of the Elp456 hetero-hexameric ring clearly identified a
preferential orientation of the Elp456 ring on the Elp123 sub-
complex (Appendix Fig S1D). Comparing to Elp1, Elp3, and Elp4,
we observed only very few inter-subunit crosslinks in Elp2, Elp5,
and Elp6. This may result from the lower level of disordered regions
in Elp2, Elp5, and Elp6, but also may suggest that these subunits
simply share less and smaller interfaces with the other subunits. In
summary, we detected a unique set of distance restraints between
the six Elongator subunits.
A
C E F
B D
Figure 2. EM reconstruction of endogenous Elp123 sub-complex.
A SDS–PAGE gel showing the purified Elp123 sub-complex used as input for gel filtration. Protein bands marked with asterisks presumably correspond to different
phosphorylation states of Elp1.
B Representative negative-stain EM field of the Elp123 sub-complex. Particles in side and top views are highlighted. Scale bar, 50 nm.
C Reference-free class averages and back-projections of the Elp123 model. Scale bar, 20 nm.
D EM reconstruction of the Elp123 sub-complex at 27 Å resolution.
E Fitting of the Elp1 CTD into the Elp123 reconstruction.
F Fitting of the Elp2 crystal structure in the difference density generated by subtracting the partial Elp123 reconstruction from the complete Elp123 reconstruction.
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The Elp1 dimer forms a scaffold for the Elp2 and Elp3 binding in
the Elp123 sub-complex
Since the EM map of Elp123 sub-complex did not allow the unam-
biguous fitting of all Elongator components, we used a previously
established integrative approach for modeling based on the combi-
nation of EM maps and crosslinks [39,40]. This approach performs
global fitting of subunits or their domains in EM maps to maximize
their fit to both the EM density and the crosslinks, optimize connec-
tivity between domains of the same protein, and minimize the steric
overlap between the domains.
As starting structures of the subunits, we used homology models
of the WD40 domains of Elp1, a composite model of the Elp1-CTD
dimer based on the yeast and human Elp1-CTD structures, the Elp2
crystal structure, and a homology model of Elp3 based on DmcElp3.
Short loops and tails that were missing in the crystal structures or
homology models, but formed crosslinks potentially useful for posi-
tioning the subunits were included as flexible loops and a-helices in
accordance with secondary structure predictions. Although the exact
conformation of such loops is difficult to predict, they can help in
restraining the orientation of structured domains [41]. Overall, 30
out of 116 crosslinks could be mapped to the respective starting
structures.
The best-scoring model fits to the Elp123 negative-stain EM map,
fills 93% of the map volume, and recapitulates its characteristic
shape (Fig 4A). Twenty-eight out of 30 (93%) crosslinks satisfy the
distance threshold between crosslinked Ca atoms of 30 A˚. The two
crosslinks that remain violated link the K401 residue from a helix
located in a long loop not present in the Elp3 crystal structure with
distant regions of Elp3 and Elp1-CTD. Thus, these crosslinks can be
explained either by structural flexibility or the expected 5% false-
positive rate of the XL-MS. The satisfied crosslinks define the loca-
tions and orientation of the subunits. The location as well as the
orientation of Elp3 is defined by crosslinks from the N-terminus of
Elp3 to Elp2 and from the Elp3-KAT domain to the second WD40
domain of Elp1 and Elp1-CTD (Fig 4B). The orientation of Elp2 in
the wing of the map is restrained by crosslinks from the N-terminal
WD40 domain of Elp2 to Elp1-CTD and the N-terminus of Elp3
(Fig 4B).
In summary, the model reveals the overall architecture of the
Elp123 sub-complex of Elongator. The scaffold of the structure is
formed by Elp1, which assumes the central position in the complex
and mediates the dimerization. The Elp1-CTD dimer forms the arch
and with its N-terminal WD40 domains creates a docking platform
for Elp3. Elp2 is located peripherally attached to Elp1-CTD and Elp3.
All subunits contribute to the formation of the central cavity, which
consists of the space between the two lobes and extends toward the
Elp2 wings.
Topological model of the holoElongator
The above model of the Elp123 sub-complex is a suitable starting
point for generating the model of the holoElongator. Thus, to build
the complete model of the Elongator complex based on the EM
Figure 3. XL-MS analyses of fully assembled Elongator.
Schematic overview of highly confident (LD score at least 30) crosslinks between Elp1 (orange), Elp2 (yellow), Elp3 (pink), Elp4 (green), Elp5 (blue), and Elp6 (sand). The
size of the used squares is adjusted to the length of the individual proteins and also indicated the location of the respective crosslinks. Inter-crosslinks are drawn as lines
colored according to one of the linked subunits, intra-crosslinks as arcs colored according the subunit, whereas “dimeric” crosslinks (linking same residues of a protein)
are depicted as red loops. Structural domains are indicated. Protein regions not present in the crystal structures and homology models are colored black. Figure was drawn
using xiNET [76].
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map, we fitted our Elp123 structural model and the known Elp456
crystal structure. Because of the observed conformational devia-
tions in the EM map of holoElongator, we fitted the two Elp123
lobes independently and refined the resulting model using an auto-
mated modeling procedure (see Materials and Methods). One
Elp123 lobe fits well into the lobe bound to the hexamer, with all
densities of Elp1, Elp2, and Elp3 recapitulated in the EM map.
Thirty-seven out of 39 (95%) crosslinks satisfy the distance thres-
hold of 30 A˚ between crosslinked Ca atoms. Elp2, Elp3, and part
of the Elp1-CTD also fit well to the second lobe of the map.
However, the fit is poorer for the WD40 domains of Elp1. The
Elp456 hetero-hexamer unambiguously fits to the hexameric
density, while crosslinks provide information about the relative
positions of the Elp4, Elp5, and Elp6 subunits within the hexameric
ring and about the face of the ring that interacts with Elp123 (see
below). Some loops and peripheral regions of Elp3 protrude out of
the EM density but locate close to unassigned densities linking
Elp456 and Elp3. Thus, Elp1 and Elp3 may undergo conformational
changes upon binding of the Elp456 sub-complex.
The resulting model agrees with the crosslinks between the
Elp456 and Elp123 sub-complexes (Fig 4C). Firstly, one of the
copies of Elp4 locates close to Elp3, satisfying the crosslinks to Elp3.
A C
B D
Figure 4. Integrative models of the Elp123 sub-complex and the holoElongator complex.
Models are shown in ribbon representation fitted to the corresponding EMmaps. The lysine–lysine crosslinks are mapped on themodels. The crosslinks are colored blue if they
are satisfied (Ca–Ca atoms of the linked positions less than 30 Å apart) or red if violated. The crosslink visualization was created with the Xlink Analyzer plugin for UCSF
Chimera [77].
A The model of the Elp123 sub-complex.
B Crosslinks supporting the orientation of Elp3 (left) and Elp2 (right). The crosslinks are shown separately to highlight crosslinks linking from Elp3 and Elp2 to other
subunits, respectively.
C The model of holoElongator.
D Crosslinks supporting the orientation of the Elp456 hexamer.
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The same Elp4 molecule is also close to the N-terminal WD40 of
Elp1, likely explaining crosslinks to this domain (Fig 3). The second
copy of Elp4 is placed close to the Elp1-CTD, enabling crosslinks
from Elp4 to that region of Elp1 (Fig 4D). Clearly, crosslinks to both
the CTD and the N-terminal WD40 domain of Elp1 can only be satis-
fied in the observed lateral ring position. The Elp456 positioning
also explains the presence of crosslinks exclusively on one side of
the ring (Appendix Fig S1D).
Our structural models suggest that the Elp456 hexamer is
placed exactly on top of the cleft containing the Elp3 active site.
The comparison of the maps also revealed that Elp123 lobes
moved relatively to each other, at the hinge region in the middle
of Elp1-CTD (Figs 1F and 2E). Thus, in addition to the presence
of Elp456, the Elp123 lobes of holoElongator significantly deviate
from the C2 symmetry observed in the Elp123 sub-complex. In
summary, we provided topological models of the Elp123 sub-
complex and holoElongator by integrative modeling, which are
based on the combination of determined EM structures and XL-
MS data.
Functional in vivo and in vitro experiments validate the
Elongator model
In order to validate the newly discovered subunit interfaces of these
models, we performed biochemical, biophysical, and functional
in vivo experiments. In detail, we used individually purified S. cere-
visiae Elp1, Elp2, and Elp456 proteins and the KAT and SAM
domains of Elp3 in different protein–protein interaction assays.
Consistent with our crosslinking results and as predicted from our
model, we observed that Elp1 interacts directly with the KAT
domain of Elp3, but requires Elp456 to interact with the SAM
domain of Elp3. In the presence of Elp1, Elp456 interacts with the
SAM domain of Elp3, but not with its KAT domain (Fig 5A). We
observed that Elp451–2706 directly interacts with the SAM domain of
Elp3 as predicted, though a large excess of protein is required. In
addition, we observed that in the presence of Elp1, the SAM domain
of Elp3 and Elp456 seem to interact stronger, confirming the dense
interaction network between Elp1, Elp3, and Elp4 in our XL-MS
approach and the holoElongator model. However, N- and C-termin-
ally truncated Elp456 (Elp466–42651–2706) [20] do neither interact
with the SAM domain of Elp3 nor tether Elp1 to the SAM domain
(Fig 5B).
Considering the rather surprising asymmetrical localization of
Elp456, we were also interested in mapping the interacting regions
between Elp123 and Elp456 more precisely. Firstly, a loop region in
Elp4 (aa168–233) that contained a large number of inter-subunit
crosslinks with Elp1 and intra-subunit crosslinks with the N-
terminus of Elp4, is dispensable for the interaction between Elp1
and Elp4. Thus, we show that the highly conserved ten first residues
of the Elp4 N-terminus, which also shows several intra-crosslinks to
the above-mentioned loop (aa168–233), are important for the inter-
action between Elp1 and the Elp456 sub-complex (Fig 5C). Elp4 by
itself interacts with the first WD40 domain of Elp1 (aa42–431;
Appendix Fig S2A) and, accordingly, a deletion of the short
conserved stretch at the N-terminus of Elp4 abolishes the interaction
between Elp11–734 and Elp4 (Fig 5D). Moreover, we used isothermal
titration calorimetry (ITC) to confirm that synthetic peptides
(aa1–10 and aa1–27) of the conserved region directly interact with
the purified N-terminal region of Elp1 (Kd 1–10 = 2.7 lM  0.3,
Kd 1–27 = 1.6 lM  0.4; Appendix Fig S2B). Interestingly, we
observed that this interacting region between Elp1 and Elp456 is salt
sensitive (Appendix Fig S2C), which has also been described for the
interaction of the endogenous Elp123 and Elp456 sub-complexes
[28]. Although the N-terminus of Elp4 is most likely unstructured
and its length is not highly conserved, our model supports the
presence of an interaction between the N-terminus of Elp4 and the
N-terminal WD40 domain of Elp1.
Finally, to understand the contribution of individual conserved
surface residues in Elp2, we mutated residues in the previously
identified [30] basic region (R626, R628, R654, R675), which was
described to be important for histone acetylation and microtubule
binding. Mutating these residues also leads to phenotypes associ-
ated with tRNA modification defects. Furthermore, we also show
that two additional regions (aa201–204 and aa552–557) seem to be
important for Elongator activity as they show similar phenotypes
(Fig EV5A and B). Accordingly, the former region (aa201–204)
contributes to formation of the cavity around the active site,
together with Elp1-CTD and Elp3, in which Elp456 binds. None of
the tested mutations affects the stability of Elp2 (Fig EV5C) and we
therefore believe that these regions are involved in protein–protein
interactions.
Discussion
Here, we determine the overall architecture of the endogenous
eukaryotic Elongator complex and propose the relative position
and orientation of the individual subunits within the fully assem-
bled complex. Our study, together with a study published by Setia-
putra et al [42] in the same issue, confirms that Elp456
asymmetrically interacts with the Elp123 sub-complex, to form
holoElongator. Although the atomic positioning of Elp3 and the
WD40s of Elp1 will require additional studies, the presented
models suggest that Elp1 provides a scaffold for Elp2 and Elp3 and
also acts as the docking platform for Elp456 (Fig 6A). In detail, the
active site of Elp3 is located in the conserved cavity formed by
Elp3, the N-terminal WD40 domain of Elp2, and the a-solenoid
domain of Elp1-CTD (Appendix Fig S3A and B). The region of Elp2
contributing to the cavity includes residues 201–204, which were
found to be important for tRNA modification activity of Elongator
(Fig 6B). Furthermore, Elp3 is located close to the region of Elp1
implicated in tRNA binding (aa1221–1259) [43], suggesting that
Elp3 and Elp1 might be able to simultaneously bind to a single
tRNA molecule (Fig 6B).
Overall, our model agrees with the independently identified
protein–protein interfaces between Elp1, Elp3, and Elp456 and with
the relative orientation of the conserved regions of all individual
subunits (Appendix Fig S3C–E). In detail, Elp3 is mostly anchored
to Elp1 via its KAT domain, agreeing with our observations that
Elp1 interacts with the KAT domain, but only shares a very small
interface with the SAM domain of Elp3 (Fig 6C). Although the
Elp456 hexamer is placed exactly on top of the cleft containing Elp3
active site, biochemical analyses suggest that the ring is also teth-
ered to Elp123, via additional interactions, one of them between the
flexible N-terminal residues of Elp4 and the first WD40 domain of
Elp1 (Fig 6A). The position of Elp456 close to the active site of Elp3
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A B
C D
Figure 5. Validation of the Elp123 and holoElongator models.
A GST pull-down assays of purified GST-tagged Elp3 SAM domain (aa72–389) and KAT domain (aa348–557) with untagged full-length Elp1 and Elp451–2706. GSH resin
and proteins were used as input controls. Lower panel shows 5% of the input and upper panel shows bound fractions. All samples were analyzed by SDS–PAGE and
stained by Coomassie. Identities of respective proteins are indicated on the right.
B Same as (A), but using only GST-tagged Elp3 SAM domain with combinations and variants of Elp1, Elp2, and Elp456.
C Same as (A) using GST-tagged full-length Elp1 and truncations and deletions of Elp456.
D Same as (A) using GST-tagged C-terminally truncated Elp1 in combination with truncated versions of Elp4.
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strongly suggests a direct role of the Elp456 sub-complex in tRNA
recruitment prior to the modification reaction or clearance of the
tRNA after the reaction. In that respect, it is surprising that the
Elp456 sub-complex interacts asymmetrically only with one side of
the Elp123 sub-complex and it remains to be shown what triggers
the polarized interaction with a symmetric Elp123 sub-complex. We
currently hypothesize that binding of Elp456 to one side of Elp123
induces a conformational change within the holocomplex that
hinders a second copy of Elp456 to bind to the second lobe. This
would be in accordance with the relative movement observed
between the lobes when comparing the Elp123 and the holoElonga-
tor EM models, in which they come closer to each other and form a
more compact structure. It is also worth mentioning that deletions
of any of the six subunits lead to similar phenotypes [44], suggest-
ing that despite the asymmetrical localization of Elp456, all compo-
nents are equally important for Elongator activity.
A
B
C D
Figure 6. Model of Elongator’s tRNA modification reaction.
A Overview of holoElongator and individual domains important for the interaction of Elp123 with Elp456. Elp1 (orange), Elp2 (yellow), Elp3 (pink), Elp4 (green), Elp5
(blue), and Elp6 (sand) are shown in surface representation to indicate the topological nature of our model. Individual domains are labeled.
B Same as (A) but tilted view to highlight the active site cavity (left). Close-up view of the active site in which all known tRNA binding sites and a region of Elp2
important for tRNA modification activity are highlighted. Individual structures of the subunits are shown in cartoon and surface representation.
C Close-up view on the localization of Elp3 and the orientation of its KAT and SAM domains in relation to Elp1 and Elp2.
D Close-up view on the relative spatial orientation of the conserved basic patch in Elp2 and the potential interaction site between Elp456 and a region of Elp2
important for tRNA modification activity. The potential tRNA binding site in Elp3 is indicated (arrow and circle).
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In addition, residues 552–557 of Elp2, which were found to be
important for tRNA modification, locate to the interfaces between
Elp3 and Elp5 (Fig 6D). Although we show that mutating the resi-
dues of this patch (R626, R628, R654, R675) affects Elongator’s
activity, it is not involved in protein–protein interactions within the
Elp123 sub-complex (Fig 6D). Therefore, this conserved basic patch
of Elp2, which was also implicated in microtubule binding, could
indeed be available for the interaction with other factors or stabilize
the Elongator assembly in different conformational states.
Notably, we fitted a monomeric model of Elp3 using integrative
modeling, although DmcElp3 was shown to form monomers and
dimers in solution. Restraining yeast Elp3 to its equivalent dimeric
conformation (as observed in the crystal structure of DmcElp3) led
to several crosslink violations and to worse fits to the EM map. On
the one hand, eukaryotic Elp3s might not need to directly dimerize,
due to the presence and function of the other five subunits, partially
absent in archaea and completely lacking in bacteria. On the other
hand, other cofactors, for example, Kti11/Kti13, which are not
present in our protein preparations, might promote dimerization of
Elp3 or induce conformational changes of the whole complex. As
we were neither able to reconstitute Elp2 containing complexes
from bacterially expressed subunits nor found an interaction of Elp2
with any of the other five subunits in GST pull-down assays, it
remains to be shown whether and which known [33,34] or
unknown posttranslational modifications are responsible for the
stable interaction of Elp2 with the other Elongator subunits.
The position of the active center in the model of the holocomplex
provides important mechanistic insights on the tRNA modification
activity. Previously, we showed that ATP binding promotes dissoci-
ation of tRNA from Elp456 [20]. Thus, we speculate that tRNA mole-
cules are delivered to the Elp123 complex via initial binding to the
Elp456 ring and that the intrinsic ATPase activity of Elp456 triggers
the dissociation of tRNA from the ring, which allows the transfer
from Elp456 to the Elp123 complex.
Last but not least, our structural analyses of Elp123 and holo-
Elongator also confirm the finding that the C-terminus of Elp1 is
essential for the assembly of the overall Elongator complex. Interest-
ingly, this region is missing in a subpopulation of familial dysau-
tonomia (FD) patients, due to a heterozygous mutation that leads to
splicing defect and results in the expression of a substantially C-
terminal truncation of Elp1 [45]. From our analyses, it becomes
obvious that the presence of a truncated form of Elp1 would lead to
a disassembly of the full complex and diminished tRNA modifi-
cation activity [46].
Materials and Methods
Yeast strains and fermentation
Saccharomyces cerevisiae strains BS1173 (MATa; ade2-1;his3-11,15;
leu2-3,112; Dtrp1; ura3-1; can1-100; Elp1-TAP::TRP1) and BSY2369
(MATa; ade2-1;his3-11,15; leu2-3,112; Dtrp1; ura3-1; can1-100;
Elp6-TAP::TRP1) were generated as described previously [47,48].
Yeast cells were grown on a fresh YPD plate and then transferred to
a 150-ml flask of YPD with 0.05% adenine sulfate and incubated for
24 h at 30°C and 180 rev/min. This pre-inoculum was seeded into
1 l of the same medium, which after 6–7 h incubation in identical
conditions was used to inoculate 100 l YPDA. Cells were grown in a
BIOSTAT D-DCU fermentor (Sartorius) for 16 h at 30°C and
150 rev/min to an OD600 of 5–6, harvested by centrifugation and
stored at 80°C until use.
TAP purifications
Tandem-affinity purification purifications were performed as
described previously [20]. In detail, 1,500 g (BSY2369 strain) and
390 g (BS1173 strain) of cells were suspended in buffer A (250 mM
HEPES pH 7.9, 125 mM NaCl, 0.1% NP-40, 1 mM DTT, 10% glyc-
erol, 1 mM PMSF) supplemented with protease inhibitor cocktail
(Complete EDTA-free, Roche) and lysed at 4°C with glass beads in a
BeadBeater (BioSpec). The soluble fraction obtained after centrifu-
gation (1 h at 30,000 g in a Beckmann JA14 rotor) was incubated
with 5 ml pre-equilibrated IgG Sepharose (GE Healthcare) for 4–6 h.
After washing with buffer B (50 mM HEPES pH 7.9, 125 mM NaCl,
0.1% NP-40, 1 mM DTT, supplemented with protease inhibitor
cocktail, and 10% glycerol for the BSY2369 strain) and buffer C
(10 mM HEPES pH 7.9, 125 mM NaCl, 0.1% NP-40, 0.5 mM EDTA,
1 mM DTT, and 10% glycerol for the BSY2369 strain), the IgG beads
were mixed with TEV protease and incubated overnight at 4°C. The
supernatant was recovered and the resin was further washed with
buffer C. Then, three column volumes of buffer D (10 mM HEPES
pH 7.9, 125 mM NaCl, 1 mM MgAcetate, 1 mM imidazole, 2 mM
CaCl2, 10 mM 2-mercaptoethanol, and 10% glycerol for the
BSY2369 strain) supplemented with 3 mM CaCl2 (final concentra-
tion) were added to the sample that was subsequently incubated
with 5 ml of Calmodulin Sepharose (GE Healthcare) for 2–4 h. After
washing with buffer D, the sample was eluted in buffer E (10 mM
HEPES pH 7.9, 125 mM NaCl, 1 mM MgAcetate, 1 mM imidazole,
2 mM EGTA, 10 mM 2-mercaptoethanol). The sample was concen-
trated to 0.3 mg/ml (Elp123) and 0.2 mg/ml (Elongator), cross-
linked with 0.01% glutaraldehyde (Electron Microscopy Sciences)
for 1 h at 4°C, and quenched with 40 mM Tris–HCl buffer (final
concentration) for 10 min at 4°C. The final purification step
comprises a gel filtration using a Superose 6 Increase 3.2/300
column (GE Healthcare) in buffer F (10 mM HEPES pH 7.9, 125 mM
NaCl, 5 mM 2-mercaptoethanol). Crosslinked Elp123 complex was
analyzed by Western blotting with TAP-tag antibody (Thermo Scien-
tific) and anti-Elp2 antibody (polyclonal, 1:2,000).
Individual proteins expression and purification
The codon-optimized sequences of Elp1, Elp2, Elp3, and Elp4 were
subcloned into the pETM30 vector to obtain N-terminally 6xHis-
GST-tagged proteins and transformed into BL21 pSarRare E. coli.
Cultures were grown at 37°C until OD600 ~1, and protein expression
was induced using 0.5 mM isopropyl-b-D-thiogalactopyranoside
(IPTG), incubated at 18°C overnight, and harvested the next morn-
ing by centrifugation. Pellets were resuspended in lysis buffer
(50 mM Tris–Cl pH 7.5, 300 mM NaCl, 20 mM imidazole, 1 mM
MgCl2, 5% glycerol, 2 mM 2-mercaptoethanol, protease inhibitor
tablets (Roche), DNase, and lysozyme) and lysed using a high-
pressure homogenizer. The lysate was cleared by centrifugation at
15,000 g for 1 h at 4°C, and the supernatant was incubated with
NiNTA resin for 2 h at 4°C. The bound protein was washed with
wash buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 1 mM MgCl2,
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5% glycerol, 2 mM 2-mercaptoethanol) and eluted with elution
buffer (50 mM Tris pH 7.5, 300 mM NaCl, 250 mM imidazole,
1 mM 2-mercaptoethanol). Subsequently, the eluted protein was
either dialyzed (20 mM Tris pH 7.5, 300 mM NaCl, 20 mM imida-
zole, 1 mM 2-mercaptoethanol) in the presence of TEV protease at
4°C overnight or directly applied to a S200 (26/60) gel filtration
column (GE Healthcare) equilibrated in gel filtration buffer (20 mM
HEPES pH 7.5, 150 mM NaCl, 5 mM DTT) to obtain GST-tagged
versions. The cleaved tag was removed using a second NiNTA step
and flow-through was also applied to gel filtration column. Fractions
were analyzed by SDS–PAGE, pooled, and concentrated. Single
amino acid substitutions were generated using the QuikChange
mutation kit (Agilent Technologies). All mutant proteins were
expressed and purified like the wild-type protein.
Full-length His6-tagged ScElp3 (ScElp3H6) was recombinantly
expressed in E. coli together with GroEL (plasmid pGroEL kindly
provided by Dr. Aguilar Netz, Marburg) and solubilized from inclu-
sion bodies in buffer containing 8 M urea. Affinity purification on
Ni-NTA-agarose was performed in the presence of 8 M urea
followed by Fe/S cluster reconstitution in vitro in an anaerobic
chamber [49]. Shortly, 53 mg of the apoprotein was first allowed to
assemble iron at room temperature in a reaction volume of 150 ml
containing 10 mM Tris–HCl, pH 7.5, 2 mM DTT, 8 M urea, and
220 lM ammonium Fe (III) citrate. After 5 min of incubation, S-
adenosylmethionine (SAM) was added to a final concentration of
350 lM. 10 ml 10 mM Tris–HCl pH 7.5 supplemented with freshly
prepared 20 mM Li2S and 2 mM DTT was added and folding was
continued for 20 min. The resulting protein preparation was
dialyzed against 10 mM Tris–HCl pH 7.5 and 150 mM NaCl and
concentrated 40-fold by Amicon tubes with 50-kDa MWCO
membrane before it was anaerobically applied to a gel filtration
column (HiLoadTM/60 Superdex 200 Prep. Grade) in 10 mM
Tris–HCl, pH 7.5; 150 mM NaCl buffer supplemented with fresh
1 mM NaDTH to prevent oxidation of reconstituted Fe/S cluster.
The reconstituted ScElp3H6 protein eluted as a single peak and was
stored in anaerobic tubes.
Crosslinking mass spectrometry analyses
50 lg (1 mg/ml) of purified Elongator complex was crosslinked by
addition of an iso-stoichiometric mixture of H12/D12 isotope-coded,
di-succinimidyl-suberate (DSS) or di-succinimidyl-glutarate (DSG,
Creative Molecules). Equal amounts of crosslinker were added ten
times every 4 min to a final concentration of 0.5–2 mM. The
crosslinking reactions were allowed to proceed for 30 min at 37°C
and quenched by addition of ammonium bicarbonate to a final
concentration of 50 mM for 10 min at 37°C. Crosslinked proteins
were denatured using urea and Rapigest (Waters) at a final concen-
tration of 4 M and 0.05% (w/v), respectively. Samples were
reduced using 10 mM DTT (30 min at 37°C), and cysteines were
carbamidomethylated with 15 mM iodoacetamide (30 min in the
dark). Protein digestion was performed first using 1:100 (w/w) LysC
(Wako Chemicals GmbH, Neuss, Germany) for 3.5 h at 37°C and
then finalized with 1:50 (w/w) trypsin (Promega GmbH, Mannheim,
Germany) overnight at 37°C, after the urea concentration was
diluted to 1.5 M. Samples were then acidified with 10% (v/v) TFA
and desalted using MicroSpin columns (Harvard Apparatus). Cross-
linked peptides were enriched using size exclusion chromatography
[50]. In brief, desalted peptides were reconstituted with SEC buffer
(30% (v/v) ACN in 0.1% (v/v) TFA) and fractionated using a
Superdex Peptide PC 3.2/30 column (GE) on a Ettan LC system (GE
Healthcare) at a flow rate of 50 ml/min. Fractions eluting between 1
and 1.5 ml were evaporated to dryness and reconstituted in 50 ll
5% (v/v) ACN in 0.1% (v/v) FA.
Between 2 and 10% of the amount contained in the collected
fractions were analyzed by liquid chromatography (LC)-coupled
tandem mass spectrometry (MS/MS) using a nanoAcquity UPLC
system (Waters) connected online to LTQ-Orbitrap Velos Pro instru-
ment (Thermo). Peptides were separated on a BEH300 C18
(75 × 250 mm, 1.7 mm) nanoAcquity UPLC column (Waters) using
a stepwise 60-min gradient between 3% and 85% (v/v) ACN in
0.1% (v/v) FA. Data acquisition was performed using a top-20
strategy where survey MS scans (m/z range 375–1,600) were
acquired in the Orbitrap (R = 30,000) and up to 20 of the most
abundant ions per full scan were fragmented by collision-induced
dissociation (normalized collision energy = 40, activation
Q = 0.250) and analyzed in the LTQ. In order to focus the acquisi-
tion on larger crosslinked peptides, charge states 1, 2 and unknown
were rejected. Dynamic exclusion was enabled with repeat
count = 1, exclusion duration = 60 s, list size = 500, and mass
window  15 ppm. Ion target values were 1,000,000 (or 500 ms
maximum fill time) for full scans and 10,000 (or 50 ms maximum
fill time) for MS/MS scans. The sample was analyzed in technical
duplicates (for DSG crosslinker) or triplicates (for DSS crosslinker).
To assign the fragment ion spectra, raw files were converted to
centroid mzXML using the Mass Matrix file converter tool and then
searched using xQuest [51] against a fasta database containing the
sequences of the crosslinked proteins. Posterior probabilities were
calculated using xProphet, and results were filtered using the
following parameters: FDR = 0.05, min delta score = 0.95, MS1
tolerance window of 4–7 ppm, ld score > 30. The mass spectrome-
try proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE [52] partner repository with the data set
identifier PXD005251.
In vitro interaction assays
Typically, 20 lg of GST-tagged proteins or mutants and increasing
amounts of untagged binding partner protein was incubated at 4°C
for 2 h with glutathione Sepharose in 20 mM Tris pH 7.5, 150 mM
NaCl, 5 mM DTT, and 0.1% Tween-20. The beads were washed five
times with incubation buffer and subsequently resuspended in SDS
loading buffer. Inputs and bound proteins were separated using
denaturing SDS–PAGE and visualized using Coomassie blue stain.
ITC measurements
Isothermal titration calorimetry was performed with a VP-ITC
Microcal calorimeter (Microcal, Northampton, MA, USA). To
measure the Elp1 Elp4 interactions, Elp1 samples were dialyzed
extensively against ITC buffer (20 mM Tris–HCl, pH 7.5, 150 mM
NaCl, 2 mM b-mercaptoethanol). Lyophilized synthesized peptides
(Peptide Specialty Laboratories, Germany) were solubilized in ITC
buffer just before use. Protein/peptide concentration in the cell was
10 lM and 100 lM in the injection syringe. The data were analyzed
using Origin software (GE Healthcare).
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Elp123 negative-stain EM and image processing
3.5 ll aliquots of freshly purified Elp123 complex were applied to
glow discharged carbon copper-collodion (Sigma) grids for 2 min
and stained with a 1% uranyl acetate solution (w/v). A total of 216
images were collected on a FEI Tecnai Spirit microscope operated at
120 kV using a Gatan Ultrascan 4000 camera at a final magnification
of 49,000×. The defocus of the selected images ranged from 1.5 to
3.5 lm and the pixel size corresponded to 2.2 A˚/pixel. Contrast
transfer function parameters were estimated using CTFFIND3 [53].
A total of 50,034 particles were semi-automatically picked using
EMAN2 [54] and subjected to reference-free classification inside
RELION [55], from which 45,650 particles were selected for sub-
sequent processing. As a starting model for the 3D classification, we
used first geometric shapes of a sphere and a cylinder slab. Second,
120 tilt pairs (0 and 55° tilt) were collected on a FEI Titan Krios at
1 lm underfocus at a pixel size of 3.78 A˚/pix. The picked 6,849
particle pairs were subjected to the random conical tilt procedure as
implemented in XMIPP [56]. Refining the geometric shapes as well
as an initial RCT model resulted in the same characteristic two-
lobed structure. Subsequently, several rounds of 3D classification
were performed and the best classes were selected based on the
comparison between the back-projections and the class averages, as
well as on their symmetric features. The first round of 3D classifi-
cation yielded two good classes (18,588 particles), and after a
second round, 6,469 particles were selected. In the third round of
3D classification, the best class showed an apparent twofold symme-
try axis (though no symmetry was previously imposed) and was
independently refined with and without C2 symmetry, yielding two
equivalent Elp123 reconstructions. The “gold standard” refinement
with C2 symmetry applied yielded a final reconstruction (2,051
particles) at 27 A˚ resolution, based on the FSC = 0.143 criterion and
35 A˚ according to the FSC = 0.5 threshold.
In addition, a fourth round of 3D classification yielded a class
lacking one of the lateral densities and thus showing no symmetry,
which would correspond to the partial Elp123 sub-complex. The
refinement step yielded a final reconstruction (1,946 particles) at
31 A˚ resolution based on the FSC = 0.143 criterion and 35 A˚ accord-
ing to the FSC = 0.5 threshold.
The back-projections of the EM models were obtained using the
“create projection library” tool in XMIPP [56].
HoloElongator negative-stain EM and image processing
3.5 ll aliquots of freshly purified holocomplex were applied to glow
discharged carbon copper-collodion (Sigma) grids for 2 min and
stained with a 1% uranyl acetate solution (w/v). A total of 204
images were collected on a FEI Tecnai Spirit microscope operated at
120 kV by using a Gatan Ultrascan 4000 camera at a final magnifi-
cation of 49,000× that corresponds to a pixel size of 2.2 A˚/pixel.
The defocus of the selected images ranged from 1.5 to 3.5 lm and
the pixel size corresponded to 2.2 A˚/pixel. Contrast transfer func-
tion parameters were estimated using CTFFIND3.
A total of 22,876 particles were semi-automatically picked using
EMAN2 and subjected to reference-free classification inside RELION,
from which 22,064 particles were selected. As a starting model for
the 3D classification, we used the Elp123 model, low-pass-filtered to
60 A˚. Four rounds of 3D classification were performed and the best
classes were selected based on the comparison between the 2D aver-
ages and the model back-projections. After the first round of 3D
classification, 7,234 particles were subjected to a second round in
which the major class gathered 5,057 particles. In the third round of
3D classification, 3,787 particles were selected from one class. After
the fourth round of 3D classification, the “gold standard“ refinement
yielded a final reconstruction (3,164 particles) at 31 A˚ resolution
based on the FSC = 0.143 criterion and 36 A˚ according to the
FSC = 0.5 threshold. A tilt-pair test [54,57,58] was performed to
confirm the handedness and correctness of our holoElongator
model.
Structural modeling
As initial structures for the modeling, we used the available crystal
structures of Elongator subunits or homology models if crystal struc-
tures were not available. For WD40 domains of Elp1, we built
homology models based on coatomer b’-subunit (PDB code: 3MKQ,
chain A) based on the alignment generated by HHpred server [59].
Due to low sequence similarity between Elp1 and coatomer b’-
subunit, these models should be regarded as low quality with the
confident assignment of the fold but uncertain sequence register.
For Elp1-CTD, we used the yeast crystal structure of Elp1-CTD (PDB
code: 5CQS) with the missing region comprising residues 739–919
added from human Elp1-CTD structure (PDB code: 5CQR) by
homology modeling. For Elp2, we used the structure published in
this work. For Elp3, we built a homology model built based on Elp3
from Dehalococcoides mccartyi (PDB code: 5L7J). This model is
predicted to be of high confidence owing to the high sequence
conservation between yeast and D. mccartyi Elp3. For Elp4, Elp5,
and Elp6, we used the crystal structure of Elp456 hexamer (PDB
code: 4A8J). Short loops and regions missing in the structures were
added to the models as flexible loops and helices based on
secondary structure predictions if they formed crosslinks potentially
useful for model. These included, for example, residues 74–86 and
375–406 of Elp3 and 1,244–1,252 of Elp1. The homology modeling
was performed using MODexplorer [60], HHpred server [59], and
Modeller [61]. The secondary structure predictions were generated
using GeneSilico MetaServer [62].
Fitting of each Elongator domain separately to the EM maps and
calculations of P-values for the fitting scores was performed as
described previously [63,64] using UCSF Chimera software [65].
Briefly, each domain was fitted using global search with an arbitrar-
ily large number of 10,000 random initial placements and a normal-
ized cross-correlation score as a fitting metric. The fits were then
clustered, in the case of Elp123 sub-complex taking the twofold
symmetry axis into account. The P-values for the cross-correlation
scores were calculated by transforming to z-scores (Fisher’s z-trans-
form) and centering, and fitting an empirical null distribution from
which two-sided P-values were computed [64].
Automated integrative modeling was performed using our previ-
ously published workflow [39] based on the UCSF Chimera, Integra-
tive Modeling Platform (IMP) package [40], version g72059d2, and
Python Modeling Interface (PMI) library (https://github.com/
salilab/pmi), version gfe8bea8.
For modeling the Elp123 sub-complex, each domain of Elp1,
Elp2, and Elp3 was firstly independently fitted to the EM map using
UCSF Chimera. The fitting was performed using a global search with
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100,000 random initial placement leading to, after clustering,
10,000–30,000 alternative fits for each domain. To ensure broad
coverage of fitting orientations and overcome that negative-stain
maps often contain artificially dense regions in the center of the
densities, which tend to “attract” the fits, the fitting was performed
with shorted optimization of 100 steps and clustering with very low
angular and the translational thresholds (cluster angle 1°, cluster
shift 1 A˚). For subsequent steps, we took the top scoring fit of Elp1-
CTD, since the fit was unambiguous for this domain, and 10,000 top
scoring fits for other domains. The fit Elp1-CTD was additionally
optimized with crude flexible fitting by generating a series of confor-
mations Normal Mode Analysis and selecting the conformation opti-
mally fitting the EM map (using the ElNemo [66] server). Then, we
generated 10,000 configurations of all Elp1, Elp2, and Elp3 domains
by recombining the above fits using simulated annealing Monte
Carlo optimization. Each configuration was generated by an inde-
pendent Monte Carlo optimization comprising 60,000 steps. The
scoring function for the optimization was a linear combination of the
normalized EM cross-correlation scores of the precalculated domain
fits, crosslinking restraint, domain connectivity restraint, and clash
score (see [39] for the implementation details). All domains were
treated as rigid bodies, including the N-terminal helices of Elp3,
which consisted rigid bodies moving independently on each other,
except short loops and linkers connecting the structured regions.
Loops and linkers that were missing in the starting structures were
excluded. The structures were simultaneously represented at two
resolutions: in Ca-only representation and a coarse-grained repre-
sentation, in which each 10-residue stretch was converted to a
bead. The 10-residue bead representation was used for the clash
score to increase computational efficiency; the Ca-only representa-
tion was used for crosslinking and domain connectivity restraints.
Since the EM restraint was derived from the original EM fits gener-
ated with UCSF Chimera, it was derived from the full atom repre-
sentation.
From the 10,000 configurations, the top scoring model was
selected and refined in Ca representation. The refinement was
performed using the same scoring function as above, but instead of
generating configuration from the predefined sets of fits, the
domains were allowed to move in continuous space and the EM
cross-correlation score was recomputed during the optimization.
The resulting Ca model was converted to the full atom representa-
tion with Modeller by using the starting domain structures and the
Ca model as constraints.
For modeling the holoElongator, we used the top scoring Elp123
model and the Elp456 crystal structure as the starting structures.
Firstly, the Elp123 model was fitted to the holoElongator map as a
rigid body using UCSF Chimera. From the fit, it was apparent that
the two lobes of Elp123 change relative orientation in the holoElon-
gator. Thus, based on the fit, we identified a hinge region around
aa. 945–960 of Elp1, and divided the Elp123 model into two lobes,
and fitted the lobes independently as rigid bodies. Then, the Elp456
was fitted to the map and the entire model was refined using the
same refinement procedure as for refining the Elp123 model.
Mapping of the sequence conservation onto protein structures was
performed using ConSurf server [67] based on the multiple
sequence alignments of Elp families retrieved from eggNOG data-
base [68]. The electrostatic potential was mapped to protein struc-
tures using Pymol and APBS [69].
Crystallization and structure determination of Elp2
Native and selenomethionine substituted crystals were grown at
18°C using the hanging drop vapor diffusion method. Purified Elp2
protein in gel filtration buffer was concentrated to 10 mg/ml and
combined with equal volume of 100 mM Tris pH 7.5, 10% PEG 6K,
1,750 mM NaCl. Crystals grew until day 2, were cryo-protected with
25% glycerol, and subsequently flash-frozen in liquid nitrogen.
Native and selenomethionine data sets for Elp2 were collected at
ESRF beamline ID14-4 equipped with a CCD camera. Data process-
ing was performed using XDS [70]. SAD phases were calculated
from identified selenium sites using autoSHARP [71]. The resulting
electron density map after solvent flattening was of good quality
and an initial model was built and subsequently refined using
Phenix [72]. The geometry of the models was validated using
Molprobity [73]. Model figures and superimpositions were prepared
using Pymol (www.pymol.org) and Coot [74].
Thermofluor analyses of Elp2 mutants
Thermostability of purified Elp2 proteins was analyzed using ther-
mofluor technology [75]. In detail, 20–50 lM of purified protein
was incubated with SYPRO Orange in 20 mM HEPES pH 7.5,
150 mM NaCl, and 5 mM DTT. Using a StepOne Plus Real-Time
PCR system (Applied Biosystems), the samples were subjected to a
temperature gradient from 20°C to 95°C (over the period of 2 h)
while simultaneously measuring the emitted fluorescence signal
(k = 590 nm).
Phenotypic analyses Elp2 mutants
A complementing clone encoding wild-type ELP2, pRS315-Elp2 was
obtained from A. Bystro¨m. A derivative, pBS4396, containing a
C-terminal TAP-tag [35] was constructed. Most of the mutant deriva-
tives were obtained by inserting in the cognate vectors three PCR
fragments covering roughly the promoter region, coding sequence,
and TAP-tag/terminator region using the Cold Fusion strategy (Sys-
tem BioSciences). For point mutants, the resulting plasmids were
generated: pBS4517 (Elp2 R626A + D627A + R628A), pBS4519
(Elp2 Y440A + D441A), pBS4520 (Elp2 D458A + E459A + K460A),
pBS4521 (Elp2 R675A), pBS4522 (Elp2 R654A), pBS4523 (Elp2
H201A + E202A + D203A + W204A), pBS4592 (Elp2 E552A-K553A-
L554A-Y555A-G556A-H557A), pBS4593 (Elp2 E597A-I598A-K599A),
pBS4594 (Elp2 R322A-E325A), pBS4857 (Elp2 R544A + H545A).
Accession numbers
The atomic coordinates and structure factors for Elp2 (PDB ID
5M2N) have been deposited with the European Protein Data Bank
(PDBe). The EM density maps of Elp123 (EMDB EMD-4151), holoE-
longator (EMD-4152), and partial Elp123 (EMD-4153) have been
deposited with the EMData Bank (EMDB).
Expanded View for this article is available online.
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